Article Information
PubMed
Print ISSN
Online ISSN
History
- Received March 19, 2018
- Accepted June 14, 2018
- Published online August 6, 2018.
Article Versions
- Earlier version (June 19, 2018 - 06:26).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Tashinga E. Bapiro,
- Andy Sykes,
- Scott Martin,
- Michael Davies,
- James W. T. Yates,
- Matthias Hoch,
- Helen E. Rollison, and
- Barry Jones
- Oncology (T.E.B., A.S., S.M., M.D., J.W.T.Y., B.J.), Quantitative Clinical Pharmacology, Early Clinical Development (M.H.), and Drug Safety and Metabolism (H.E.R.), IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom
- Address correspondence to:
Dr. Tashinga E. Bapiro, Oncology IMED Biotech Unit, AstraZeneca, Hodgkin Building c/o B310, Cambridge Science Park, Milton Road, CB4 0WG Cambridge, UK. E-mail: tashinga.bapiro1{at}astrazeneca.com